ARCHIVES

CMS Allows Medicare Payment for Eloxatin, But Says Review of New Agents Likely

This article is from The Cancer Letter archive.

Vol. 29 No. 21 | May 23, 2003

Download PDF Visit The Full Archive

Related Articles

Oral Complications Reduced By Pretherapy NIH Conference Finds

April 28, 1989

NCI advisors approve new grants programs. NCI funds consortium of cohorts. Funding opportunities listed.

August 1, 2003

Full Funding Of Indirect Costs, Other Mandates By Congress Chew Up Most Of NCI’s Extra Money

December 2, 1983

Phase III Regorafenib Trial Meets PFS Primary Endpoint

June 29, 2012

No Constitutional Right To Experimental Drugs, Appeals Court Rules Against Abigail Alliance.

August 10, 2007

Mammography Debate “Confused a Whole Generation” – Shalala

January 7, 1994